Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1

References

• BARS, R. G. and ELCOMBE, C. R., 1991, Dose-dependent acinar induction of cytochromes P450 in rat liver. Evidence for a differential mechanism of induction of P4501A1 by /3-naphthofiavone and dioxin. Biochemical Journal, 277, 577–580.
   PubMed Web of Science ®Google Scholar
• BARS, R. G., MITCHELL, A. M., WOLF, C. R. and ELCOMBE, C. R., 1989, Induction of cytochrome P-450 in cultured rat hepatocytes. The heterogeneous localisation of specific isoenzymes using immunocytochemistry. Biochemical Journal, 262, 151–158.
   PubMed Web of Science ®Google Scholar
• BRECKENRIDGE, A. M., BACK, D. J., CRAWFORD, F. E., MACrvER, M., ORME, N. and ROWE, P. H., 1980, Drug interactions with oral contraceptives: clinical and experimental studies. International Congress Symposium Series—Royal Society of Medicine, 31, 1–11.
   Google Scholar
• BURRIS, T. P., PELTON, P. D., Zitou, L., OSBORNE, M. C., CRYAN, E. and DEMAREST, K. T., 1999, A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator -activated receptor y agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Molecular Endocrinology, 13, 410–417.
   PubMed Web of Science ®Google Scholar
• DOGRA, S. C., WrirrELAw, M. L. and MAY, B. K., 1998, Transcriptional activation of cytochrome P450 genes by different classes of chemical inducers. Clinical and Experimental Pharmacology and Physiology, 25, 1–9.
   PubMed Web of Science ®Google Scholar
• GONZALEZ, F. J., PETERS, J. M. and CATTLEY, R. C., 1998, Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activated receptor alpha. Journal of the National Cancer Institute, 90, 1702–1709.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., 1988, Oxidation of 17 a-ethynylestradiol by human liver cytochrome P-450. Molecular Pharmacology, 33, 500–508.
   PubMed Web of Science ®Google Scholar
• JARVIS, B. and FAULDS, D., 1998, Nelfinavir: a review of its therapeutic efficacy in HIV infection. Drugs, 56, 147–167.
   PubMed Web of Science ®Google Scholar
• KADLUBAR, F. F. and GUENGERICH, F. P., 1992, Inducibility of human cytochromes P-450 primarily involved in the activation of chemical carcinogens. Chemosphere, 25, 201–204.
   Web of Science ®Google Scholar
• KIMURA, S., HANIOKA, N., MATSUNAGA, E. and GONZALEZ, F. J., 1989, The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organisation, and identification of a conserved 19-bp upstream element. DNA, 8, 503–516.
   PubMedGoogle Scholar
• KIRITA, S. and MATSUBARA, T., 1993, cDNA cloning and characterisation of a novel member of steroid-induced cytochrome P450 3A in rats. Archives of Biochemistry and Biophysics, 307, 253–258.
   PubMed Web of Science ®Google Scholar
• KRVISTO, K. T., VILLIKKA, K., NYMAN, L., ANrimA, M. and NEUVONEN, P. J., 1998, Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin. Clinical and Phar-macological Therapeutics (St Louis), 64, 648–654.
   PubMed Web of Science ®Google Scholar
• KLIEWER, S. A., MOORE, J. T., WADE, L., STAUDINGER, J. L., WATSON, M. A., Jos, S. A., McKEE, D. D., OLIVER, B. B., WILLSON, T. M., ZETTERSTROM, R. H., PERLMANN, T. and LEHMANN, J. M., 1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell (Cambridge, Mass.), 92, 73–82.
   PubMed Web of Science ®Google Scholar
• KOCAREK, T. A., SCHUETZ, E. G., STROM, S. C., FISHER, R. A. and GUZELIAN, P. S., 1995, Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition, 23, 415–421.
   PubMed Web of Science ®Google Scholar
• KOSTRUBSKY, V. E., STROM, S. C., WOOD, S. G., WRIGHTON, S. A., SINCLAIR, P. R. and SINCLAIR, J. F., 1995, Ethanol and isopentanol increase CYP3A and CYP2E in primary cultures of human hepatocytes. Archives of Biochemistry and Biophysics, 322, 516–520.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., 1995, Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annual Reviews in Pharmacology and Toxicology, 35, 483–507.
   PubMed Web of Science ®Google Scholar
• LAKE, B. G., RENWICK, A. B., CUNNINGHAME, M. E., PRICE, R. J., SURRY, D. and EVANS, D. C., 1998, Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver. Toxicology, 131, 9–20.
   PubMed Web of Science ®Google Scholar
• LAMBEG, T. S., Kivisto, K. T. and NEUVONEN, P. J., 1998, Concentrations and effects of buspirone are considerably reduced by rifampicin. British Journal of Clinical Pharmacology, 45, 381–385.
   PubMed Web of Science ®Google Scholar
• LEFEVRE, P. A., TINWELL, H., GALLOWAY, S. M., HILL, R., MACKAY, J. M., ELCOMBE, C. R., FOSTER, J., RANDALL, V., CALLANDER, R. D. and ASHBY, J., 1994, Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta mouse and Big Blue transgenic mice. Human Experimental Toxicology, 13, 764–775.
   PubMed Web of Science ®Google Scholar
• LEHMANN, J. M., McKEE, D. D., WATSON, M. A., WILLSON, T. M., MOORE, J. T. and KLIEWER, S. A., 1998, The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. Journal of Clinical Investigation, 102, 1016–1023.
   PubMed Web of Science ®Google Scholar
• Li, A. P., MAUREL, P., GOMEZ -LECHON, M. J., CHENG, L. C. and JUREVIA -ROMET, M., 1997a, Preclinical evaluation of drug—drug interaction potential: Present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction. Chemico-Biological Interactions, 107, 5–16.
   Google Scholar
• Li, A. P., REITH, M. K., RASIVIUSSEN, A., GORSKI, J. C., HALL, S. D., Xu, L., KAMINSKI, D. L. and CHENG, L. K., 1997b, Primary human hepatocytes as a tool for the evaluation of structure—activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. Chemico-Biological Interactions, 107, 17–30.
   PubMed Web of Science ®Google Scholar
• MEYER, U. A., GONZALEZ, F. J., GUENGERICH, F. P., McMANus, M. E. and OKUDA, K.-I., 1995, Human cytochromes P450 : regulation and functional variability. In A. Cuello (ed.), Conference Proceeding, 1994 (Basle: Birkhaeuser), pp. 153–159.
   Google Scholar
• MICHALETS, E. L., 1998, Update: clinically significant cytochrome P-450 drug interactions. Pharmaco-therapy, 18, 84–112.
   Google Scholar
• MIYATA M., NAGATA, K., YAMAZOE, Y. and KATO, R., 1991, A gene structure of testosterone 6/3-hydroxylase (P450IIIA). Biochemical and Biophysical Research Communications, 177, 68–73.
   Google Scholar
• NDANUSA, B. U., MUSTAPH A. and ABDU-AGUYE, I., 1997, The effect of single dose of rifampicin on the pharmacokinetics of oral nifedipine. Journal of Pharmacology and Biomedical Annals, 15, 1571–1575.
   Google Scholar
• NELSON, D. R., 1998, Cytochrome P450 nomenclature. Methods in Molecular Biology (Totowa, NJ), 107, 15–24.
   PubMedGoogle Scholar
• NISHIBE, Y. and HIRATA, M., 1993, Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes. Xenobiotica, 23, 681–692.
   PubMed Web of Science ®Google Scholar
• PARK, K. S., SOHN, D. H., VEECH, R. L. and SONG, B. J., 1993, Translational activation of ethanol-inducible cytochrome P450 (CYP2E1) by isoniazid. European Journal of Pharmacology, En-vironmental Toxicology and Pharmacology Section, 248, 7–14.
   Web of Science ®Google Scholar
• PARKINSON, A., 1996, An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials. Toxicology and Pathology, 24, 45–57.
   Web of Science ®Google Scholar
• REESE, J. A. and BYARD, J. L., 1981, Isolation and culture of adult hepatocytes from liver biopsies. In Vitro, 17, 935–940.
   PubMedGoogle Scholar
• RYU, D.-Y., LEVI, P. E., FERNANDEZ -SALGUERO, P., GONZALEZ, F. J. and HODGSON, E., 1996, Piperonyl butoxide and acenaphthylene induce cytochrome P450 1A2 and 1B1 mRNA in aromatic hydrocarbon response receptor knock-out mouse liver. Molecular Pharmacology, 50, 443–446.
   Google Scholar
• SAFE, S. and KRISHNAN, V., 1995, Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Archives of Toxicology, 17 (suppl.), 99–115.
   Google Scholar
• SCHRENK, D., 1998, Impact of dioxin-type induction of drug-metabolising enzymes on the metabolism of endo- and xenobiotics. Biochemical Pharmacology, 55, 1155–1162.
   PubMed Web of Science ®Google Scholar
• SCHUETZ, E. G., Li, D., OMIECINSKI, C. J., MULLER -EBERHARD U., KLEINIVIAN, H. K., ELswicK, B. and GUZELIAN, P. S., 1988, Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. Journal of Cellular Physiology, 134, 309–323.
   Google Scholar
• SHARER, J. E., SHIPLEY, L. A., VANDENBRANDEN, M. R., BINKLEY, S. N. and WRIGITTON, S. A., 1995, Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabolism and Disposition, 23, 1231–1241.
   PubMed Web of Science ®Google Scholar
• SOGAWA, K., GOTOH O., KAWAJIRI, K. and Fum -KuRuzAiviA, Y., 1984, Distinct organisation of methylcholanthrene - and phenobarbital-inducible cytochrome P-450 genes in the rat. Proceedings of the National Academy of Sciences, USA, 81, 5066–5070.
   Google Scholar
• SOGAWA, K., GOTOH O., KAWAJIRI, K., HARADA, T. and FUJIE -KURIYAMA, Y., 1985, Complete nucleotide sequence of a methylcholanthrene-inducible cytochrome P-450 (P-450d) gene in the rat. Journal of Biological Chemistry, 260, 5026–5032.
   Google Scholar
• SPATZENEGGER, M. and JAEGER, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews, 27, 397–417.
   PubMed Web of Science ®Google Scholar
• STROM, S. C., JIRTLE, R. L., Jos, R. S., NOVICKI, D. L., ROSENBERG, M. R., NOVOTNY, A., IRONS, G., McLAINT, J. R. and MICHALOPOULOS, G., 1982, Isolation, culture, and transplantation of human hepatocytes. Journal of the National Cancer Institute, 68, 771–778.
   PubMed Web of Science ®Google Scholar
• STROTKAMP, D., Roos, P. H. and HANSIEIN, W. G., 1995, A novel CYP3 gene from female rats. Biochi mica et Biophysica Acta, 1260, 341–344.
   PubMed Web of Science ®Google Scholar
• SURRY, D., MCALLISTER, G., MENESES -LORENTE, G. and EVANS, D. C., 1999, High throughput ribonuclease protection assay for the determination of CYP3A mRNA induction in cultured rat hepatocytes. Xenobiotica, 29, 827–838.
   PubMed Web of Science ®Google Scholar
• VAN DEN BROEK, P. J. A., BARROSO, M. and LECHNER, M. C., 1996, Critical amino-terminal segments in insertion of rat liver cytochrome P450 3A1 into the endoplasmic reticulum membrane. Experientia, 52, 851–855.
   Google Scholar
• WANG, T. and BROWN, M. J., 1999, mRNA Quantification by real time TaqMan polymerase chain reaction: validation and comparison with RNase protection. Analytical Biochemistry, 269, 198–201.
   PubMed Web of Science ®Google Scholar
• WEAVER, R. J., THOMPSON, S., SMITH, G., DicHiNs, M., ELCOMBE, C. R., MAYER, R. T. and BURKE, M. D., 1994, A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763–773.
   PubMed Web of Science ®Google Scholar
• WILLEY, J. C., COY, E. L., FRAMPTON, M. W., TORRES, A., APOSTOLAKOS, M. J., HOEHN, G., SCHUERMANN, W. H., THILLY, W. G., OLSON, D. E., HAMMERSLEY, J. R., CRESPI, C. L. and UTELL, M. J., 1997, Quantitative RT-PCR measurement of cytochromes P450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. American Journal of Respiratory Cell and Molecular Biology, 17, 114–124.
   PubMed Web of Science ®Google Scholar
• WORTELBOER, H. M., DE KRUIF, C. A., DE BOER, W. I., VAN TEASEL, A. A. J., FALKE, H. E. and BLAAUBOER, B. J., 1988, Induction and activity of several isoenzymes of cytochrome P-450 in primary cultures of rat hepatocytes, in comparison with in vivo data. Molecular Toxicology, 1, 373–381.
   Google Scholar
• WRIGHT, M. C., PAINE, A. J., SKETT, P. and AULD, R., 1994, Induction of rat hepatic glucocorticoid-inducible cytochrome P450 3A by metyrapone. Journal of Steroid Biochemistry and Molecular Biology, 48, 271–276.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A. and STEVENS, J. C., 1992, The human hepatic cytochromes P450 involved in drug metabolism. Critical Reviews in Toxicology, 22, 1–21.
   PubMed Web of Science ®Google Scholar